Research shows vascular brain injury from conditions such as high blood pressure and stroke poses greater risk factors for cognitive impairment than the deposition of the amyloid plaques in the brain that long have been implicated in conditions such as Alzheimer's disease.
This is according to a study by researchers at the Alzheimer's Disease Research Center at UC Davis.
The study found that vascular brain injury had by far the greatest influence across a range of cognitive domains, including higher-level thinking and the forgetfulness of mild cognitive decline.
The researchers also sought to determine whether there was a correlation between vascular brain injury and the deposition of beta amyloid plaques, thought to be an early and important marker of Alzheimer's disease, said Bruce Reed, associate director of the UC Davis Alzheimer's Disease Research Center in Martinez, Calif.
They also sought to decipher what effect each has on memory and executive functioning.
"The more vascular brain injury the participants had, the worse their memory and the worse their executive function - their ability to organize and problem solve," Reed said.
The research was conducted in 61 male and female study participants who ranged in age from 65 to 90 years old, with an average age of 78. Thirty of the participants were clinically "normal," 24 were cognitively impaired and seven were diagnosed with dementia, based on cognitive testing. The participants had been recruited from Northern California between 2007 to 2012.
The study participants underwent magnetic resonance imaging (MRI) ? to measure vascular brain injury ? and positron emission tomography (PET) scans to measure beta amyloid deposition: markers of the two most common pathologies that affect the aging brain. Vascular brain injury appears as brain infarcts and "white matter hyperintensities" in MRI scans, areas of the brain that appear bright white.
The study found that both memory and executive function correlated negatively with brain infarcts, especially infarcts in cortical and sub-cortical gray matter. Although infarcts were common in this group, the infarcts varied greatly in size and location, and many had been clinically silent. The level of amyloid in the brain did not correlate with either changes in memory or executive function, and there was no evidence that amyloid interacted with infarcts to impair thinking.
Reed said the study is important because there's an enormous amount of interest in detecting Alzheimer's disease at its earliest point, before an individual exhibits clinical symptoms.
It's possible to conduct a brain scan and detect beta amyloid in the brain, and that is a very new development, he said.
The study was published online in JAMA Neurology (formerly Archives of Neurology).